Level Biotechnology Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 163.8 million compared to TWD 151.64 million a year ago. Net income was TWD 14.99 million compared to TWD 16.83 million a year ago. Basic earnings per share from continuing operations was TWD 0.46 compared to TWD 0.52 a year ago. Diluted earnings per share from continuing operations was TWD 0.46 compared to TWD 0.52 a year ago.
For the six months, sales was TWD 307.84 million compared to TWD 268.28 million a year ago. Net income was TWD 31.4 million compared to TWD 27.81 million a year ago. Basic earnings per share from continuing operations was TWD 0.97 compared to TWD 0.86 a year ago. Diluted earnings per share from continuing operations was TWD 0.96 compared to TWD 0.85 a year ago.